Articles from ValGenesis, Inc.

ValGenesis, Inc., the global leader in digital validation lifecycle management, today announced a strategic partnership with CAI, a professional services firm specializing in accelerating operational readiness in mission-critical environments, to expand the use of artificial intelligence (AI) in life sciences validation.

ValGenesis, Inc., the global innovator in digital validation lifecycle management, today announced the launch of ValGenesis Smart GxP™, the first AI-enabled platform purpose-built to unify validation and process lifecycle management across the life sciences industry. Smart GxP digitally connects all stages of the product lifecycle to provide a closed-loop feedback cycle, from process development and validation to commercial manufacturing. It delivers unprecedented efficiency, streamlined digital tech transfer, enhanced visibility, compliance through intelligent automation, seamless data integration, and accelerated time to market.

ValGenesis, the global leader and first mover in digital validation lifecycle management, will unveil its latest breakthrough, VAL: AI-Enabled Validation Assistant, at INTERPHEX 2025. Designed to fundamentally transform how validation is conducted in regulated life sciences companies, VAL is an intelligent assistant that automates validation document creation, enables right-first-time execution, and drives exception-based reviews―dramatically reducing cycle times and costs.

ValGenesis, Inc., the market leader in digital validation lifecycle management solutions, announced that a global pharmaceutical and biotechnology leader has successfully expanded its use of the ValGenesis digital validation platform by deploying iClean, a risk-based cleaning validation solution that digitizes the entire cleaning validation lifecycle.

ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Compliance Group (CG), a quality excellence and regulatory compliance solutions provider based in the U.S., announced their partnership to help life sciences companies achieve faster adoption and value through superior digital validation solutions.

ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Systems (VLMS), today announced the appointment of Terrance Blackwell as Chief Delivery Officer (CDO). In this strategic role, Terrance will drive the evolution of ValGenesis' customer-centric product delivery strategy, propelling the company into its next phase of innovation and growth.

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), announced today that Rottendorf Pharma, a prominent contract development and manufacturing organization (CDMO) based in Germany, has chosen ValGenesis VLMS to digitize its corporate validation process.

ValGenesis, the market leader in digital validation and risk management solutions for life sciences, is thrilled to announce the appointment of David Medina as Chief Marketing Officer (CMO), effective September 3, 2024. David joins ValGenesis with an impressive track record of driving marketing success across the enterprise SaaS, life sciences, and technology sectors.

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a rapidly expanding contract development and manufacturing organization (CDMO), serving a global market, selected ValGenesis e-Logbook to digitize logbook management across its manufacturing sites.

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Validator K.K., a reputed Japanese validation products and services company, have entered into a strategic reseller partnership that leverages Validator’s unique on-site validation services model for the Japanese life sciences sector.

ValGenesis successfully concluded ValConnect, its annual customer and partner conference, in Lisbon on Wednesday, June 19th, after hosting an impressive series of product announcements and customer success stories to customers, partners, and industry experts.

ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Zamann Pharma Support, a life sciences technology and consulting company based in Germany, have entered into a strategic alliance to address quality assurance and compliance challenges for life sciences companies in Europe.

ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Célere, a life sciences-focused consultancy in California, have partnered to deliver best-in-class digital validation solutions for companies across the U.S. and Europe.

ValGenesis Inc., the market leader in digital validation software solutions for life sciences, today announced the launch of VLMS 5.0, the revolutionary new version of its flagship digital validation lifecycle management software poised to transform the industry's approach to digital transformation.

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a global science and technology company selected ValGenesis VLMS to digitize the computer system validation process across its manufacturing sites.

Continuing its rapid pace of innovation in digital validation technology, ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS) will unveil the next version of VLMS and an enhanced portfolio of cutting-edge solutions at ValConnect 2024 Europe, its annual European user conference to be held in Lisbon, Portugal.

ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Adryan, a full-service life sciences consultancy in the Netherlands and Switzerland, have partnered to deliver best-in-class digital validation solutions for the (bio)- pharmaceutical, medical devices, and novel therapies industries across Europe.

ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and DynaCompliance Pvt. Ltd., a compliance and validation solutions company, have partnered to strategically advance the adoption of ValGenesis’ industry-leading suite of digital validation solutions for life sciences companies across India and the US.

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a leading global biotechnology company selected ValGenesis iRisk to digitalize the quality risk management processes across its manufacturing sites.

ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Contrader, an Italian information and communication technology (ICT) company, have partnered to advance the ValGenesis VLMS product suite and Contrader’s immense ICT expertise across the life sciences sector in Italy.

ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), has acquired Portugal-based 4Tune Engineering (4TE), a leader in manufacturing sciences and technologies (MS&T) that enable the world’s most successful life sciences companies to model their risk management programs and improve process performance across the entire GMP lifecycle.